Maven Securities’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Maven Securities’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-124,278	Closed	-$4.89M	–	1256
2023 Q2	$4.89M	Buy	+124,278	New	+$4.39M	0.07%	133
2021 Q3	–	Sell	-242,289	Closed	-$1.47M	–	1352
2021 Q2	$1.47M	Buy	+242,289	New	+$1.56M	0.06%	313
2020 Q3	–	Sell	-50,000	Closed	-$255K	–	780
2020 Q2	$255K	Buy	+50,000	New	+$208K	0.02%	450

Maven Securities's ISEE Position: Q3 2023 in Review

Maven Securities sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 124,278 shares — an estimated $4.89M sold.

Maven Securities first reported a position in ISEE in Q2 2020 and held it in 3 quarters. The position peaked at $4.89M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Maven Securities reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Maven Securities sold 124,278 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $4.89M.
Maven Securities first reported a position in IVERIC bio, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
Maven Securities's IVERIC bio, Inc. Common Stock position peaked at $4.89M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Maven Securities's 13F filing for Q3 2023, filed 13 Nov 2023.